Commitments & Contingencies (Details) |
3 Months Ended |
|---|---|
|
Jun. 30, 2025
USD ($)
$ / shares
shares
| |
| Commitments & Contingencies [Line Items] | |
| Deferred fee percentage | 3.50% |
| Percentage of deferred underwriting commission | 3.50% |
| Deferred underwriting commission | $ 2,012,500 |
| Fair value of unit purchase option | 208,093 |
| UPO [Member] | |
| Commitments & Contingencies [Line Items] | |
| Sold to purchase unit | $ 100 |
| Unit purchase option (in Shares) | shares | 270,250 |
| Units exercisable per share (in Dollars per share) | $ / shares | $ 11 |
| Aggregate exercise price | $ 2,972,750 |
| Expire date | 5 years |
| Cash payment | $ 100 |
| Fair value of unit purchase option | $ 208,093 |
| Fair value per share (in Dollars per share) | $ / shares | $ 0.77 |
| Volatility | 12.96% |
| Risk free interest rate | 1.61% |
| Expected life | 5 years |
| Probability of successful combination | 85.00% |
| Underwriters [Member] | |
| Commitments & Contingencies [Line Items] | |
| Gross proceeds | $ 2,012,500 |
| X | ||||||||||
- Definition An aggregate exercise price is the total value of some underlying asset if one were to exercise all of their existing long options contracts on that asset. No definition available.
|
| X | ||||||||||
- Definition Cash from exercise of unit purchase option. No definition available.
|
| X | ||||||||||
- Definition Deferred fees percentage. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of deferred underwriting commission. No definition available.
|
| X | ||||||||||
- Definition Fair value of unit purchase option. No definition available.
|
| X | ||||||||||
- Definition Percentage of deferred underwriting commission. No definition available.
|
| X | ||||||||||
- Definition Probability of successful combination, percentage. No definition available.
|
| X | ||||||||||
- Definition Unit purchase option means the underwriter ’s option to purchase. No definition available.
|
| X | ||||||||||
- Definition Unit purchase option expiration term. No definition available.
|
| X | ||||||||||
- Definition Exercisable options require completion of a vesting schedule. No definition available.
|
| X | ||||||||||
- Definition Fair value per share that would be issued upon settlement of option contract indexed to equity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The risk-free interest rate assumption that is used in valuing an option on its own shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for option under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|